AAP Circumcision Task Force 2012

Aus IntactiWiki
Version vom 17. November 2019, 18:51 Uhr von WikiAdmin (Diskussion | Beiträge) (Die Seite wurde neu angelegt: „{{NYT en}} The persons listed here are members of the American Academy of Pediatrics Task Force responsible for the 2012 Pol…“)
(Unterschied) ← Nächstältere Version | Aktuelle Version (Unterschied) | Nächstjüngere Version → (Unterschied)
Zur Navigation springen Zur Suche springen
(Dieser Artikel wurde noch nicht aus dem Englischen übersetzt oder enthält noch englische Textpassagen. Bitte beziehe dich vorerst auf die Informationen im englischen Artikel. Klicke dazu in der IntactiWiki-Navigation im Abschnitt "In anderen Sprachen" auf "English".)

The persons listed here are members of the American Academy of Pediatrics Task Force responsible for the 2012 Policy Statement on Circumcision, as listed at the end of the Policy Statement.[1]

Task Force on Circumcision 2012

  • Susan Blank, MD, MPH, Chairperson
  • Michael Brady, MD, Representing the Committee on Pediatric AIDS
  • Ellen Buerk, MD, Representing the AAP Board of Directors
  • Waldemar Carlo, MD, Representing the AAP Committee on Fetus and Newborn
  • Douglas Diekema, MD, MPH, Representing the AAP Committee on Bioethics
  • Andrew Freedman, MD, Representing the AAP Section on Urology
  • Lynne Maxwell, MD, Representing the AAP Section on Anesthesiology and Pain Medicine
  • Steven Wegner, MD, JD, Representing the AAP Committee on Child Health Financing

Liaisons

Consultants

  • Susan K. Flinn, MA – Medical Writer
  • Esther C. Janowsky, MD, PhD

Staff

  • Edward P. Zimmerman, MS

Task Force on Circumcision 1999

Members of the Task Force on circumcision 1998-1999[2]

Summary of Policy Statement 1999
Existing scientific evidence demonstrates potential medical benefits of newborn male circumcision; however, these data are not sufficient to recommend routine neonatal circumcision. In the case of circumcision, in which there are potential benefits and risks, yet the procedure is not essential to the child’s current well-being, parents should determine what is in the best interest of the child. To make an informed choice, parents of all male infants should be given accurate and unbiased information and be provided the opportunity to discuss this decision. It is legitimate for parents to take into account cultural, religious, and ethnic traditions, in addition to the medical factors, when making this decision. Analgesia is safe and effective in reducing the procedural pain associated with circumcision; therefore, if a decision for circumcision is made, procedural analgesia should be provided. If circumcision is performed in the newborn period, it should only be done on infants who are stable and healthy.[3]
  • Carole M. Lannon, MD, MPH, Chairperson
  • Ann Geryl Doll Bailey, MD
  • Alan R. Fleischman, MD
  • George W. Kaplan, MD
  • Craig T. Shoemaker, MD
  • Jack T. Swanson, MD
  • Donald Coustan, MD

Einzelnachweise

  1. REFweb Circumcision Policy Statement, United States of America, American Academy of Pediatrics. Abgerufen 27. August 2012.
    Zitat: Task Force on Circumcision
  2. REFweb Circumcision Policy Statement 1999, United States of America, American Academy of Pediatrics. Abgerufen 26. September 2012.
    Zitat: Task Force on Circumcision 1999
  3. http://pediatrics.aappublications.org/content/103/3/686.full.pdf+html